Rafael Amado
Director/Board Member bij POSEIDA THERAPEUTICS, INC.
Vermogen: 508 947 $ op 31-03-2024
Profiel
Momenteel bekleedt Rafael G. Amado de functie van Chief Medical Officer, EVP-Research & Development bij Allogene Therapeutics, Inc. In het verleden was hij President-Research & Development bij Adaptimmune Therapeutics Plc, Senior Vice President bij GlaxoSmithKline Plc, Executive Director-Therapeutic Oncology bij Amgen Ltd. en Assistent Klinisch Professor aan de University of California, Los Angeles. Rafael G. Amado behaalde een doctoraat aan de Universiteit van Sevilla.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2023 | 77 135 ( 0.05% ) | 344 793 $ | 31-03-2024 | |
| 01-05-2023 | 39 300 ( 0.04% ) | 125 367 $ | 31-03-2024 | |
ZAI LAB LTD.
0.00% | 04-04-2024 | 23 532 ( 0.00% ) | 38 787 $ | 31-03-2024 |
Actieve functies van Rafael Amado
| Bedrijven | Functie | Begin |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Director/Board Member | 13-04-2023 |
Eerdere bekende functies van Rafael Amado
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30-12-2022 |
| ADAPTIMMUNE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 12-08-2019 |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a private company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 01-07-2019 |
| GSK PLC | Corporate Officer/Principal | 01-03-2015 |
Amgen Ltd.
 Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01-08-2008 |
Opleiding van Rafael Amado
| University of Seville | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| GSK PLC | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Amgen Ltd.
Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Adaptimmune LLC
Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a private company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Health Services |
